Baxter International cash flow, quarter by quarter
Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$558M in Q3 2026 · $1.6B over twelve months
Operating cash flow$558M
Free cash flow+$558M
Cash / net income1.9×
Cash conversion cycle114 days
Analysis
In Q3 2026, Baxter International generated $558M of operating cash flow. That is $321M more than in Q3 2025 ($237M).
Over the twelve months to Sep 30, 2026, operating cash flow was $1.6B; the largest uses were net borrowing (+) / repaid (−) ($2.6B), other investing ($558M), dividends ($102M); besides operations, cash came from other financing ($1.9B), shares issued ($24.0M); the cash balance rose by $253M.
Operating cash flow was $558M against net income of $294M — 1.9× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$239M, receivables +$74.0M, inventory −$46.0M.
Its cash conversion cycle was 114 days (receivables 56 + inventory 106 − payables 48).
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $558M, Capital spending $0.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $7.0B; the largest uses were acquisitions ($10.8B) and net borrowing ($8.2B). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$2.0B
Debt$9.4B
Net debt$7.5B
Due within a year$844M
Baxter International funds itself: free cash flow was $1.6B over the last twelve months, and $2.0B of cash and investments stands against $9.4B of debt ($844M due within a year, 2.3× covered by cash).
Principal due in each year as disclosed in the annual report, against $2.0B of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q3 2026
56
106
48
114
Q2 2026
55
108
50
113
Q1 2026
59
113
52
121
Q4 2025
56
90
37
109
Q3 2025
58
118
48
128
Q2 2025
55
114
49
120
Q1 2025
57
108
49
115
Q4 2024
57
106
46
117
Every quarter
Quarter
Operating cash flow
Dividends
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$558M
−$5.0M
−$600M
$6.0M
$175M
$558M
Q2 2026
$285M
−$5.0M
—
$5.0M
−$137M
$285M
Q1 2026
$213M
−$5.0M
—
$8.0M
−$51.0M
$213M
Q4 2025
$584M
−$87.0M
−$2.0B
$5.0M
−$240M
$584M
Q3 2025
$237M
−$87.0M
—
$9.0M
−$40.0M
$237M
Q2 2025
$217M
−$87.0M
−$680M
$6.0M
$608M
$217M
Q1 2025
−$193M
−$87.0M
−$3.1B
$10.0M
$118M
−$193M
Q4 2024
$488M
−$147M
$296M
$8.0M
−$334M
$488M
Baxter International: income statement and cash flow
Baxter International, Q3 2026: revenue $3.0B (+5% year over year), operating margin 7.6%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.